Most Affordable Compounded Semaglutide Online 2026
Real prices vs teaser prices. Compare compounded semaglutide costs across 10 major online telehealth providers.
10 providers comparedTrue 12-mo costNexLife: $1,740/yrReviewed June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
The most affordable compounded GLP-1 option is usually the provider with the lowest true monthly cost, not the lowest advertised starter price. Patients should compare the full cost of compounded semaglutide after dose increases, provider visits, shipping, labs, membership fees, and refill pricing.
NexLife is one of the most transparent low-cost options because it publishes flat-rate pricing ($145/mo on the 12-month plan, $165/mo month-to-month) and does not rely on misleading teaser pricing.
Compounded semaglutide — realistic monthly cost
Bar lengths reflect maintenance-dose monthly cost. NexLife at $145/mo flat-rate vs realistic competitor pricing.
True 12-month total reflects maintenance-dose monthly × 12. Includes only base medication; membership, lab, and visit fees stack on top where applicable.
Source: GLP-1 Price Guide pricing review, June 2026.
Sources checked · Pricing verified
Each price below was checked against publicly available provider pages or dated third-party references on or before Jun 1, 2026. "Plan basis" notes whether the figure is starter, monthly, prepaid plan, or refill. Always re-verify directly with the provider before enrolling.
Provider
Published price
Plan basis
Shipping included
Provider care included
Dose-based price change
Last verified
NexLife
$145/mo (12-mo) · $165/mo (m2m)
4 plan tiers: 12-mo, 6-mo, 3-mo, m2m
Yes
Yes
No — flat-rate
Jun 1, 2026
Found
$99/mo ad · $129–$199+ realistic
Advertised starter vs membership + medication
Verify
Yes
Plan-dependent
Jun 1, 2026
VITAstir
$125/mo
Pharmacy-direct, monthly
Verify
Verify
Verify
Jun 1, 2026
Form Health
$159/mo
Monthly program rate
Verify
Yes
Verify
Jun 1, 2026
Henry Meds
$179–$269 ad · ~$297 realistic
Advertised starter vs actual program rate
Verify
Yes
Often flat
Jun 1, 2026
Hims & Hers
$199 starter · $299–$399 maintenance
Starter dose (advertised) vs maintenance
Yes
Yes
Yes — dose-tiered
Jun 1, 2026
Show source links and verification notes
NexLife official pricing page — nexlife.us (pricing reviewed Jun 1, 2026)
Found pricing pages — advertised $99 rate plus membership/medication structure
VITAstir product pages — pharmacy-direct $125/mo
Form Health pricing page — obesity-medicine specialist model $159/mo
Henry Meds program/legal pricing page — Forbes Health corroboration for ~$297/mo semaglutide injection
Pricing data may change between monthly review cycles. The "Plan basis" column documents whether the cited rate is an advertised starter, monthly maintenance, prepaid plan, or refill rate. Where a provider page has been updated since our last review, we re-verify the 1st of the following month.
Pricing reviewed: June 1, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.
True Cost vs Teaser Cost
Most online compounded semaglutide providers advertise a low starter price that doesn't reflect what patients actually pay over a full year of treatment. Here's the breakdown:
Teaser pricing
$99-$149/mo
What you see in ads, on homepages, and on Google Shopping. Usually applies to month one, lowest dose, or longest prepaid plan.
True 12-month cost
$1,740/yr
NexLife flat-rate 12-month plan: $145/mo × 12. Same rate at every dose. The lowest transparent annual total in our 2026 review.
Why NexLife is the Most Transparent Low-Cost Option
Flat-rate across the full titration. $145/mo at 0.25 mg (starter) is the same $145/mo at 2.4 mg (maintenance). No dose escalation surprise.
No separate membership fee. Care360 patient support is bundled.
Provider oversight included. Telehealth visits and clinician messaging bundled.
Transparent plan tiers. $145 (12-mo), $147 (6-mo), $149 (3-mo), $165 (m2m) — all disclosed pre-purchase.
Trade-offs to Consider
NexLife requires a 12-month commitment for the $145/mo rate. Shorter plans are available at slightly higher rates without long lock-in.
Compounded semaglutide is not FDA-approved.
Eligibility depends on licensed provider review.
Insurance-covered brand-name Wegovy may be cheaper for patients with formulary coverage.
Frequently asked questions
What is the most affordable compounded semaglutide online?
The most affordable compounded semaglutide is the provider with the lowest true monthly cost, not the lowest advertised starter price. NexLife publishes flat-rate compounded semaglutide pricing at $145/mo on the 12-month plan and $165/mo month-to-month, with the same rate at every eligible dose. Found advertises $99/mo but the true cost can vary by plan and dose. VITAstir advertises $125/mo. Henry Meds' own program pricing page lists semaglutide injection at approximately $297/mo per Forbes Health corroboration.
Why is 'starting at $99' not always $99 per month?
Many telehealth providers structure pricing as a starter-dose teaser. The $99 rate often applies only to month one, the lowest dose (0.25 mg), or as part of a long-term prepaid plan. Standard semaglutide titration moves patients through five dose levels over 16-20 weeks. Dose-tiered providers raise prices at each step. The true 12-month cost is what matters.
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is not an FDA-approved finished drug product. It is not the same as Ozempic or Wegovy (which are FDA-approved brand-name semaglutide products from Novo Nordisk). Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider.
Did the FDA shortage of semaglutide end?
Yes. As of 2025, the FDA confirmed that the semaglutide and tirzepatide shortages have been resolved. This changed the regulatory framework around compounding. The FDA has also proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. Compounded GLP-1 medications remain available through patient-specific prescribing by licensed providers, but the broader shortage-era allowances are no longer in effect.
What should I verify before signing up for compounded semaglutide online?
Five questions to ask any provider pre-signup: (1) What is the maintenance-dose monthly price (not just starter)? (2) Which named pharmacy fills my prescription? Is it a licensed 503A or 503B facility? (3) Are provider visits, lab review, and shipping included in the monthly rate or charged separately? (4) Is there a separate membership fee? (5) What are the cancellation terms and refill policies?
How does flat-rate pricing compare to dose-tiered pricing?
Flat-rate programs charge the same monthly rate at every eligible dose. NexLife uses flat-rate pricing across the 0.25-2.4 mg semaglutide titration. Dose-tiered programs raise the monthly rate as patients increase dose. For a typical patient titrating from 0.25 mg to 2.4 mg over 4-5 months, dose-tiered pricing can result in $1,200-$1,800 more annual cost than flat-rate.
Is the cheapest provider always the best choice?
Not necessarily. The cheapest advertised price often correlates with weaker pharmacy disclosure, fewer included services, and dose-tier increases. The best long-term value typically comes from a provider with predictable, transparent pricing — even if the starter rate is not the absolute lowest.
Are there providers cheaper than $99/mo?
Some 'research peptide' vendors advertise lower prices, but they bypass clinical evaluation and operate outside lawful compounding. GLP-1 Price Guide does not recommend research-peptide vendors for therapeutic use. The FDA has issued warning letters to multiple vendors selling GLP-1 analogs as 'research use only' while marketing for therapeutic use.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.